Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: Results of the FOSIT study

1999-05-27

Additional Metadata
Keywords	Alendronate, Bisphosphonate, Bone mineral density, Fractures, Postmenopausal osteoporosis
Persistent URL	doi.org/10.1007/PL00004171, hdl.handle.net/1765/74125
Journal	Osteoporosis International: with other metabolic bone diseases
Organisation	Department of Internal Medicine
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Pols, H., Felsenberg, D., Hanley, G., Štepán, J., Muñoz-Torres, M., Wilkin, T., … Stych, B. (1999). Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: Results of the FOSIT study. Osteoporosis International: with other metabolic bone diseases, 9(5), 461–468. doi:10.1007/PL00004171

Publication